# Reactive Nodular Fibrous Pseudotumor Presenting as Gastric Outlet Obstruction in a Young Adult Male Patient: A Case Report and Review of the Medical Literature

**Authors:** David Saulino, David Gonzalo, Michael Still, Meredith Thompson, Christopher Forsmark, Alexander Ayzengart, Michael Feely

PMC · DOI: 10.1155/crip/6943449 · Case Reports in Pathology · 2026-02-27

## TL;DR

A young adult male presented with a rare gastric tumor causing blockage, diagnosed as a reactive nodular fibrous pseudotumor.

## Contribution

This case highlights unique features of a rare pseudotumor, including calcifications and IgG4-positive plasma cells.

## Key findings

- The patient had a 5.6 cm fibrotic gastric mass with calcifications and lymphoplasmacytic inflammation.
- Immunohistochemistry showed IgG4-positive plasma cells and absence of CD117 expression.
- The case emphasizes the importance of histopathological evaluation for accurate diagnosis.

## Abstract

Mesenchymal proliferations involving the gastrointestinal tract are uncommon and often unexpected upon initial clinical presentation. Here, we are reporting a case of a 20‐year‐old male patient presenting to the hospital with abdominal pain and vomiting. Upon evaluation, the patient was initially discharged home on antacid therapy. The symptoms progressed in intensity, and a subsequent CT scan was remarkable for marked gastric expansion and a prepyloric mass. The macroscopic examination of the resected lesion revealed a 5.6 cm multilobular fibrotic mass involving the gastric wall. Microscopic analysis was notable for a spindle‐cell lesion with admixed lymphoplasmacytic inflammation, patchy necrosis, and calcifications. The immunohistochemical workup was suggestive of a reactive nodular fibrous pseudotumor. This case is notable for several aspects, including the acute clinical presentation, intralesional calcifications, abundant IgG4‐positive plasma cells, and lack of CD117 immunohistochemical expression. The peculiarities of the case and a review of the medical literature will be presented.

## Linked entities

- **Proteins:** KIT (KIT proto-oncogene, receptor tyrosine kinase)

## Full-text entities

- **Genes:** DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, ACVRL1 (activin A receptor like type 1) [NCBI Gene 94] {aka ACVRLK1, ALK-1, ALK1, HHT, HHT2, ORW2}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, ALK (ALK receptor tyrosine kinase) [NCBI Gene 238] {aka ALK1, CD246, NBLST3}, ROS1 (ROS proto-oncogene 1, receptor tyrosine kinase) [NCBI Gene 6098] {aka MCF3, ROS, c-ros-1}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, KIT (KIT proto-oncogene, receptor tyrosine kinase) [NCBI Gene 3815] {aka C-Kit, CD117, MASTC, PBT, SCFR}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, CD34 (CD34 molecule) [NCBI Gene 947], F13A1 (coagulation factor XIII A chain) [NCBI Gene 2162] {aka F13A}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, VIM (vimentin) [NCBI Gene 7431], ANO1 (anoctamin 1) [NCBI Gene 55107] {aka DOG1, INDMS, MYMY7, ORAOV2, TAOS2, TMEM16A}
- **Diseases:** lymphoma (MESH:D008223), gastric distension (MESH:D013272), MF (MESH:D005350), RNFP (MESH:D000275), mucosal injury (MESH:D052016), sarcomatoid carcinoma (MESH:D002292), chronic inactive gastritis (MESH:D005756), necrosis (MESH:D009336), abdominal wall hernia (MESH:D046449), diastasis (MESH:D000070631), ascites (MESH:D001201), GIST (MESH:D046152), obliterative phlebitis (MESH:D010689), weight loss (MESH:D015431), GOO (MESH:D017219), mucinous adenocarcinoma (MESH:D002288), peptic ulcer disease (MESH:D010437), pyloric stenosis (MESH:D011707), Gastrointestinal mesenchymal tumors (MESH:C535700), Fibrous pseudotumors (MESH:D006104), hemorrhage (MESH:D006470), abdominopelvic lesions (MESH:D009059), nausea (MESH:D009325), gastric adenocarcinoma (MESH:D013274), vomiting (MESH:D014839), IgG4 (MESH:D000077733), IFPs (MESH:C566774), CFT (MESH:C537961), inflammation (MESH:D007249), trauma (MESH:D014947), testicular lesions (MESH:D013733), schwannomas (MESH:D009442), abdominal pain (MESH:D015746), Spindle cell lesion (MESH:D002277), mucosal atrophy (MESH:D001284), IMTs (MESH:D009369), Calcifications (MESH:D002114)
- **Chemicals:** eosin (MESH:D004801), hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), omeprazole (MESH:D009853)
- **Species:** Human gammaherpesvirus 8 (no rank) [taxon 37296], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946811/full.md

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946811/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946811/full.md

---
Source: https://tomesphere.com/paper/PMC12946811